Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
about
Review: Gout: A Roadmap to Approaches for Improving Global OutcomesAllopurinol: insights from studies of dose-response relationships.ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approachesThe genetics of gout: towards personalised medicine?Predicting allopurinol response in patients with goutPopulation-specific association between ABCG2 variants and tophaceous disease in people with goutCurrent and future therapies for gout.Hyperuricemia in Tendons.Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong.A comprehensive analysis of the association of common variants of ABCG2 with gout.ABCG2 and NCF4 polymorphisms are associated with clinical outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP.PharmGKB summary: very important pharmacogene information for ABCG2.Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response.Functional non-synonymous variants of ABCG2 and gout risk.The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool.Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with goutMultiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout
P2860
Q28076018-A897F357-23F9-47E9-A6ED-38661EA3141AQ30240163-14AC26A4-5F1F-4AB4-8775-12510FF2B28AQ33602553-1AB240F0-8DCC-452E-BF36-262A461D73B8Q33750522-93A2E2A8-F817-4B0F-B5AF-644DAF13C237Q36802064-24D08576-79BB-4577-BE13-83AD2EE1047FQ37686521-C5F68792-43C6-4274-8AB2-970A68D0EE32Q38660829-0E00C7DE-16D8-4334-B3BB-2209C0406C1EQ39480194-48B106F8-EEB9-49AC-8F17-9D9584F3C5B3Q41209052-18EC9403-33E6-4DDA-AD3C-8A9725CB8C97Q41564015-40A370C3-852E-4F88-ABE3-81F412F9C2C1Q41709561-3A8DA563-1BD6-4453-9A35-3AD35CE92285Q46018199-D5E63B6D-FFE7-41BD-B6C3-4B92165699F4Q46109720-73090C6C-4F9C-450F-8775-E392216F8360Q47714692-CC2D5A9C-B3A3-4FE0-AEE6-B9661E77B8D6Q48228865-7BDD099F-5164-43F9-AA6A-403F2ED74C10Q50000842-78E2D482-F3D0-4B4B-B8E3-A01D9DB7AEF6Q53815600-426F8C1D-1F78-4D8D-8179-AD400916FDD6Q57154626-78272EF8-8186-4639-BFA2-DD11546B2CB0Q57174959-7B36758E-0039-47C0-A3C9-38F0AF910A2F
P2860
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genome-wide association study ...... determinant of drug response.
@ast
Genome-wide association study ...... determinant of drug response.
@en
type
label
Genome-wide association study ...... determinant of drug response.
@ast
Genome-wide association study ...... determinant of drug response.
@en
prefLabel
Genome-wide association study ...... determinant of drug response.
@ast
Genome-wide association study ...... determinant of drug response.
@en
P2093
P2860
P356
P1476
Genome-wide association study ...... a determinant of drug response
@en
P2093
C Schaefer
E Jorgenson
K M Giacomini
T J Hoffmann
P2860
P304
P356
10.1002/CPT.89
P407
P50
P577
2015-04-06T00:00:00Z